Neurotech shares are up 67 per cent after early results show that its device can lead to major brain changes for children with autism.
Just the abstract of a US clinical trial was accepted last week by medical journal Frontiers in Neurology, but that was enough to send the company’s shares bananas.
The company bounced to 20c after reaching a 52-week low last week... https://unauthorised investment adv...ay-childrens-brains-work-sends-stock-up-67pc/
NTI Price at posting:
18.5¢ Sentiment: Buy Disclosure: Not Held
